The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular characterization of urothelial cancer developing after pelvic radiation.
 
Tracy Lynn Rose
No Relationships to Disclose
 
Jordan Kardos
No Relationships to Disclose
 
Sara Wobker
No Relationships to Disclose
 
Matthew I. Milowsky
Research Funding - Acerta Pharma (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Incyte (Inst); Innocrin Pharma (Inst); Inovio Pharmaceuticals (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); X4 Pharma (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
William Y. Kim
Stock and Other Ownership Interests - Agios; Bristol-Myers Squibb; Johnson & Johnson; Medivation
Patents, Royalties, Other Intellectual Property - BASE47 bladder cancer subtype classifier